SOTK

Sono-Tek is seeing strong growth in medical applications, and a solid sales outlook of modest growth or flat sales for the rest of the FY. Customer concentration remains high at SOTK, with 52% of sales from two customers. In general, products need to get validated for momentum to continue. On the other hand, the success in higher ASP sales and in the sorts of things sold in the medical vertical could lend itself to follow-on sales.

Sono-Tek Corporation ( SOTK ) Q2 2027 Earnings Call October 14, 2026 10:30 AM EDT Company Participants Christopher Coccio - Executive Chairman R. Harshbarger - President, CEO & Director Stephen Bagley - Chief Financial Officer Conference Call Participants Kirin Smith - ProActive Capital Group, LLC Bill Nicklin Richard Ryan - Oak Ridge Financial Services Group Inc., Research Division Edward Jackson - Northland Capital Markets, Research Division Sam Dufault - Oak Ridge Financial Services Group Inc., Research Division Gregory Weaver - Invicta Capital Management, LLC Jason Ursaner - Bumbershoot Holdings Corp. Presentation Operator Good day, everyone, and welcome to the Sono-Tek Corporation Fiscal Year 2027 Midyear Results Conference Call.

Sono-Tek NASDAQ: SOTK reported fiscal 2027 first-half revenue growth, wider gross margins and higher profitability, led by a sharp increase in medical-market sales and demand for higher-value production systems. Management also highlighted recent order activity that it said provides increased visibility into fiscal 2028.

Sono-Tek Corporation (SOTK) came out with quarterly earnings of $0.02 per share, missing the Zacks Consensus Estimate of $0.05 per share. This compares to earnings of $0.03 per share a year ago.

First Half Revenue Increased 6% to $10.9 Million; Gross Margin Expanded to 55%; Operating Income Increased 41%; Medical Market Sales Increased 289% Reiterates Expectation of Flat to Modest Revenue Growth for FY 27 Reflecting Timing of Several Large Orders Recent New Record Orders Significantly Increases Revenue Visibility for FY 28 MILTON, N.Y., Oct. 14, 2026 (GLOBE NEWSWIRE) -- Sono-Tek Corporation (Nasdaq: SOTK), a leading developer and manufacturer of precision ultrasonic coating systems, today reported financial results for the second quarter and first half of fiscal year 2027, ended August 31, 2026.

SonoTek (SOTK) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.

Largest Single Production Line Order in Company History Will Support High-Volume Medical Diagnostic Manufacturing MILTON, N.Y., Aug.

Sono-Tek Corporation (SOTK) came out with quarterly earnings of $0.05 per share, in line with the Zacks Consensus Estimate . This compares to earnings of $0.03 per share a year ago.

Revenue Increased 10%; Gross Margin Expanded to 57%; Operating Income Increased 86%; Net Income Increased 67% Anticipating Continued Revenue Growth in 1H 2027 Driven by Strong Medical Sector and Higher Value Production Systems MILTON, N.Y., July 08, 2026 (GLOBE NEWSWIRE) -- Sono-Tek Corporation (Nasdaq: SOTK), a leading developer and manufacturer of precision ultrasonic coating systems, today reported financial results for the first quarter of fiscal 2027, ended May 31, 2026.

SonoTek (SOTK) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.